chitosan has been researched along with Allodynia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chuttani, K; Mathur, R; Mishra, AK; Misra, A; Naik, S; Patel, D | 1 |
| Girotra, P; Kumar, A; Singh, SK; Thakur, A | 1 |
| Cai, YQ; Chen, SR; Han, HD; Lopez-Berestein, G; Pan, HL; Sood, AK | 1 |
3 other study(ies) available for chitosan and Allodynia
| Article | Year |
|---|---|
Intranasal delivery of cyclobenzaprine hydrochloride-loaded thiolated chitosan nanoparticles for pain relief.
Topics: Administration, Intranasal; Amitriptyline; Animals; Brain; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Epithelial Cells; Humans; Hyperalgesia; Mice; Nanoparticles; Pain; Permeability; Tissue Distribution | 2013 |
Identification of multi-targeted anti-migraine potential of nystatin and development of its brain targeted chitosan nanoformulation.
Topics: Animals; Bradykinin; Brain; Chitosan; Drug Carriers; Drug Evaluation, Preclinical; Drug Liberation; Grooming; Hyperalgesia; Male; Mice; Migraine Disorders; Molecular Docking Simulation; Molecular Targeted Therapy; Nanoparticles; Nystatin; Particle Size; Photophobia; Protein Conformation; Software | 2017 |
Role of M2, M3, and M4 muscarinic receptor subtypes in the spinal cholinergic control of nociception revealed using siRNA in rats.
Topics: Acetylcholine; Animals; Biocompatible Materials; Chitosan; Ganglia, Spinal; Gene Expression Regulation; Hyperalgesia; Injections, Spinal; Male; Muscarine; Muscarinic Agonists; Protein Binding; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Receptor, Muscarinic M4; Receptors, Muscarinic; RNA, Small Interfering; Spinal Cord | 2009 |